Table 2

Number of participants achieving each identified clinical target at baseline, 3 months, and 6 months by treatment group

CC groupACM + HT groupP
n7364
A1C <7%
    Baseline00
    3 months4 (5.5)9 (14.1)0.14
    6 months4 (5.5)13 (20.3)0.01
A1C <8%
    Baseline6 (8.2)7 (10.9)0.77
    3 months17 (23.3)34 (53.1)<0.001
    6 months25 (34.2)37 (57.8)<0.01
A1C <9%
    Baseline29 (39.7)25 (39.1)>0.99
    3 months47 (64.4)54 (84.4)0.01
    6 months49 (67.1)54 (84.4)0.03
Systolic blood pressure ≤130 mmHg
    Baseline19 (26.0)18 (28.1)0.85
    3 months28 (39.7)29 (45.3)0.49
    6 months34 (46.6)30 (46.9)>0.99
Diastolic blood pressure ≤80 mmHg
    Baseline42 (57.5)39 (60.9)0.73
    3 months46 (63.0)43 (71.9)0.72
    6 months53 (72.6)50 (78.1)0.55
LDL cholesterol <100 mg/dl*
    Baseline36 (52.2)31 (52.5)>0.99
    3 months44 (63.8)43 (72.9)0.34
    6 months41 (59.4)47 (79.7)0.02
Triglyceride ≤150 mg/dl
    Baseline43 (58.9)33 (51.6)0.39
    3 months39 (53.4)42 (65.6)>0.17
    6 months42 (57.5)40 (62.5)>0.60
  • Data are n (%).

  • *For LDL cholesterol, denominators are 69 for the CC group and 59 for the ACM + HT group.